Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months
Crossref DOI link: https://doi.org/10.1007/s12325-021-02023-y
Published Online: 2022-02-12
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanihara, Hidenobu
Kakuda, Takahiko
Sano, Tetsuro
Kanno, Takashi
Kurihara, Yuji
Funding for this research was provided by:
Kowa Co., Ltd.
Text and Data Mining valid from 2022-02-12
Version of Record valid from 2022-02-12
Article History
Received: 28 October 2021
Accepted: 15 December 2021
First Online: 12 February 2022